Haleon Us Holdings Drug Patent Portfolio
Haleon Us Holdings owns 10 orange book drugs protected by 21 US patents with Advil Allergy Sinus having the least patent protection, holding only 1 patent. And Flonase Sensimist Allergy Relief with maximum patent protection, holding 8 patents. Given below is the list of Haleon Us Holdings's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11918693 | Ibuprofen and acetaminophen tablet | 09 Jul, 2041 | Active |
| US8501164 | Nicotine lozenge compositions | 14 Jun, 2029 | Active |
| US8940772 | Nicotine lozenge composition | 30 Apr, 2029 | Active |
| US8147461 | Fluid dispensing device | 15 Oct, 2028 | Active |
| US8347879 | Fluid dispensing device | 15 Jul, 2028 | Active |
| US8323683 | Flavoring of drug-containing chewing gums | 30 Apr, 2028 | Active |
| US7863287 | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines | 28 Feb, 2027 | Active |
| US8062264 | Fluid dispensing device | 05 Apr, 2026 | Active |
| US8752543 | Fluid dispensing device | 05 Apr, 2026 | Active |
| US9320862 | Fluid dispensing device | 06 Nov, 2024 | Expired |
| US10238640 | Pharmaceutical suspension composition | 25 May, 2024 | Expired |
| US8263647 | Treatment of sleep disturbances | 30 May, 2022 | Expired |
| US8883849 | Treatment of sleep disturbances | 17 Jan, 2022 | Expired |
| US9155718 | Treatment of sleep disturbances | 17 Jan, 2022 | Expired |
| US6858596 | Formulation containing anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
| US7101866 | Anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
| US7541350 | Formulation containing anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
| US6004996 | Tetrahydrolipstatin containing compositions | 06 Jan, 2018 | Expired |
| US5972916 | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine | 14 Jul, 2017 | Expired |
| US4874794 | Inflammatory disease treatment | 28 Apr, 2014 | Expired |
| US5534554 | Sucrose ester-C20 to C28 alcohol formulations | 13 Dec, 2013 | Expired |
Latest Legal Activities on Haleon Us Holdings's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Haleon Us Holdings.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Jun, 2024 | US8347879 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 May, 2024 | US8323683 |
|
Maintenance Fee Reminder Mailed
Critical
| 29 Apr, 2024 | US8263647 |
| Patent eGrant Notification | 05 Mar, 2024 | US11918693 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Mar, 2024 | US11918693 |
| Recordation of Patent eGrant | 05 Mar, 2024 | US11918693 |
| Mail Patent eGrant Notification | 05 Mar, 2024 | US11918693 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Mar, 2024 | US11918693 |
|
Email Notification
Critical
| 05 Mar, 2024 | US11918693 |
|
Email Notification
Critical
| 15 Feb, 2024 | US11918693 |
|
Issue Notification Mailed
Critical
| 14 Feb, 2024 | US11918693 |
| Dispatch to FDC | 30 Jan, 2024 | US11918693 |
|
Application Is Considered Ready for Issue
Critical
| 30 Jan, 2024 | US11918693 |
|
Issue Fee Payment Verified
Critical
| 23 Jan, 2024 | US11918693 |
|
Issue Fee Payment Received
Critical
| 23 Jan, 2024 | US11918693 |
Haleon Us Holdings Drug Patents' Oppositions Filed in EPO
Haleon Us Holdings drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jan 23, 2015, by Galenicum Health S.L.. This opposition was filed on patent number EP03813818A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP06770085A | Apr, 2015 | Fertin Pharma A/S | Revoked |
| EP03813818A | Jan, 2015 | Galenicum Health S.L. | Revoked |
Haleon Us Holdings's Family Patents
Haleon Us Holdings Drug List
Given below is the complete list of Haleon Us Holdings's drugs and the patents protecting them.
1. Abreva
Abreva is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US4874794 | Inflammatory disease treatment |
28 Apr, 2014
(10 years ago)
| Expired |
| US5534554 | Sucrose ester-C20 to C28 alcohol formulations |
13 Dec, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Abreva's drug page
2. Advil Allergy Sinus
Advil Allergy Sinus is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7863287 | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
28 Feb, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advil Allergy Sinus's drug page
3. Advil Dual Action With Acetaminophen
Advil Dual Action With Acetaminophen is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11918693 | Ibuprofen and acetaminophen tablet |
09 Jul, 2041
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advil Dual Action With Acetaminophen's drug page
4. Advil Pm
Advil Pm is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263647 | Treatment of sleep disturbances |
30 May, 2022
(2 years ago)
| Expired |
| US8883849 | Treatment of sleep disturbances |
17 Jan, 2022
(2 years ago)
| Expired |
| US9155718 | Treatment of sleep disturbances |
17 Jan, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advil Pm's drug page
5. Alli
Alli is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6004996 | Tetrahydrolipstatin containing compositions |
06 Jan, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alli's drug page
Explore Our Curated Drug Screens
6. Children's Advil Allergy Sinus
Children's Advil Allergy Sinus is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10238640 | Pharmaceutical suspension composition |
25 May, 2024
(6 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Advil Allergy Sinus's drug page
7. Children's Advil-flavored
Children's Advil-flavored is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10238640 | Pharmaceutical suspension composition |
25 May, 2024
(6 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Advil-flavored's drug page
8. Excedrin (migraine Relief)
Excedrin (migraine Relief) is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5972916 | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
14 Jul, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Excedrin (migraine Relief)'s drug page
9. Flonase Sensimist Allergy Relief
Flonase Sensimist Allergy Relief is protected by 8 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8147461 | Fluid dispensing device |
15 Oct, 2028
(3 years from now)
| Active |
| US8347879 | Fluid dispensing device |
15 Jul, 2028
(3 years from now)
| Active |
| US8062264 | Fluid dispensing device |
05 Apr, 2026
(1 year, 3 months from now)
| Active |
| US8752543 | Fluid dispensing device |
05 Apr, 2026
(1 year, 3 months from now)
| Active |
| US9320862 | Fluid dispensing device |
06 Nov, 2024
(a month ago)
| Expired |
| US6858596 | Formulation containing anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
| US7101866 | Anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
| US7541350 | Formulation containing anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flonase Sensimist Allergy Relief's drug page
10. Nicorette
Nicorette is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8501164 | Nicotine lozenge compositions |
14 Jun, 2029
(4 years from now)
| Active |
| US8940772 | Nicotine lozenge composition |
30 Apr, 2029
(4 years from now)
| Active |
| US8323683 | Flavoring of drug-containing chewing gums |
30 Apr, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nicorette's drug page